Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3101.T Stock Summary
Top 10 Correlated ETFs
3101.T
In the News
3101.T Financial details
Company Rating
Neutral
Market Cap
100.52B
Income
-8.84B
Revenue
408.51B
Book val./share
2145.83
Cash/share
316.84
Dividend
40
Dividend %
3.72%
Employees
10.89K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-9.9
Forward P/E
-
PEG
0.59
P/S
0.24
P/B
0.5
P/C
3.45
P/FCF
-
Quick Ratio
0.63
Current Ratio
1.47
Debt / Equity
1.21
LT Debt / Equity
0.61
-
-
EPS (TTM)
-99.47
EPS next Y
-
EPS next Q
-
EPS this Y
-105.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.65%
Revenue last 5Y
3.5%
Revenue Q/Q
5.42%
EPS Q/Q
-117.38%
-
-
-
-
SMA20
-0.8%
SMA50
2.28%
SMA100
9.57%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-5%
ROC
0.01%
Gross Margin
20%
Oper. Margin
1%
Profit Margin
-2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
980.0-1182.0
52W High
-7.53%
52W Low
+11.53%
RSI
45
Rel Volume
1.09
Avg Volume
339.34K
Volume
369K
Perf Week
-1.53%
Perf Month
-1.26%
Perf Quarter
8.54%
Perf Half Y
7.95%
-
-
-
-
Beta
0.588
-
-
Volatility
20.69%, 20.72%
Prev Close
-1.8%
Price
1093
Change
-5.37%
3101.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.79K | 3.82K | 3.8K | 4.23K | 4.5K | |
Net income per share | -6.79 | 155.12 | 47.3 | 144.75 | -7.37 | |
Operating cash flow per share | 88.3 | 498.4 | 394.31 | 192.37 | 87.73 | |
Free cash flow per share | -184.72 | 150.88 | 84.8 | -135.19 | -352.82 | |
Cash per share | 152.61 | 200.48 | 307.91 | 203.77 | 576.87 | |
Book value per share | 1.99K | 2K | 2.09K | 2.19K | 2.13K | |
Tangible book value per share | 2K | 2K | 2.07K | 2.17K | 2.44K | |
Share holders equity per share | 1.99K | 2K | 2.09K | 2.19K | 2.13K | |
Interest debt per share | 1.85K | 1.95K | 2.07K | 2.13K | 2.55K | |
Market cap | 129.25B | 101.49B | 126.5B | 97.14B | 92.35B | |
Enterprise value | 270.25B | 247.63B | 274.72B | 257.66B | 256.81B | |
P/E ratio | -214.34 | 7.37 | 30.1 | 7.55 | -140.99 | |
Price to sales ratio | 0.38 | 0.3 | 0.37 | 0.26 | 0.23 | |
POCF ratio | 16.49 | 2.29 | 3.61 | 5.68 | 11.84 | |
PFCF ratio | -7.88 | 7.58 | 16.79 | -8.09 | -2.94 | |
P/B Ratio | 0.73 | 0.57 | 0.68 | 0.5 | 0.49 | |
PTB ratio | 0.73 | 0.57 | 0.68 | 0.5 | 0.49 | |
EV to sales | 0.8 | 0.73 | 0.81 | 0.69 | 0.64 | |
Enterprise value over EBITDA | 7.74 | 6.91 | 6.75 | 5.82 | 9.61 | |
EV to operating cash flow | 34.48 | 5.6 | 7.84 | 15.07 | 32.93 | |
EV to free cash flow | -16.48 | 18.48 | 36.47 | -21.44 | -8.19 | |
Earnings yield | 0 | 0.14 | 0.03 | 0.13 | -0.01 | |
Free cash flow yield | -0.13 | 0.13 | 0.06 | -0.12 | -0.34 | |
Debt to equity | 0.92 | 0.96 | 0.98 | 0.96 | 1.19 | |
Debt to assets | 0.35 | 0.35 | 0.37 | 0.36 | 0.38 | |
Net debt to EBITDA | 4.04 | 4.08 | 3.64 | 3.63 | 6.16 | |
Current ratio | 1.47 | 1.69 | 1.62 | 1.63 | 1.48 | |
Interest coverage | 16.65 | 16.65 | 20.78 | 23.48 | 7.58 | |
Income quality | 76.84 | 2.24 | 6.28 | 1.16 | 12.74 | |
Dividend Yield | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
Payout ratio | -5.89 | 0.26 | 0.84 | 0.28 | -5.43 | |
Sales general and administrative to revenue | 0.11 | 0.11 | 0.12 | 0.11 | 0.12 | |
Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -3.09 | -0.7 | -0.78 | -1.7 | -5.02 | |
Capex to revenue | -0.07 | -0.09 | -0.08 | -0.08 | -0.1 | |
Capex to depreciation | -1.53 | -1.81 | -1.44 | -1.45 | -2.06 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 551.4 | 2.64K | 1.49K | 2.67K | 594.69 | |
ROIC | -0.51 | 0.04 | 0.03 | 0.06 | -0.03 | |
Return on tangible assets | 0 | 0.03 | 0.01 | 0.03 | 0 | |
Graham Net | -1.84K | -2.01K | -1.88K | -2.01K | -2.02K | |
Working capital | 61.36B | 84.1B | 81.52B | 92.56B | 96.63B | |
Tangible asset value | 177.57B | 178B | 183.96B | 192.84B | 216.79B | |
Net current asset value | -86.7B | -99.82B | -89.59B | -81.31B | -68.35B | |
Invested capital | 0.92 | 0.96 | 0.98 | 0.96 | 1.19 | |
Average receivables | 86.28B | 89.5B | 93.58B | 97.64B | 100.98B | |
Average payables | 44.02B | 42.2B | 41.27B | 43.88B | 50.16B | |
Average inventory | 74.05B | 78.71B | 78.47B | 86.18B | 108.98B | |
Days sales outstanding | 92.79 | 100.38 | 101.42 | 98.62 | 91.68 | |
Days payables outstanding | 61.02 | 59.6 | 60.4 | 61.19 | 61.93 | |
Days of inventory on hand | 109.66 | 115.35 | 112.75 | 125.39 | 141.29 | |
Receivables turnover | 3.93 | 3.64 | 3.6 | 3.7 | 3.98 | |
Payables turnover | 5.98 | 6.12 | 6.04 | 5.96 | 5.89 | |
Inventory turnover | 3.33 | 3.16 | 3.24 | 2.91 | 2.58 | |
ROE | 0 | 0.08 | 0.02 | 0.07 | 0 | |
Capex per share | -273.02 | -347.52 | -309.51 | -327.56 | -440.55 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.1K | 1.14K | 1.1K | 1.16K | 1.22K | |
Net income per share | -13.61 | -117.33 | -5.77 | 28.6 | -4.97 | |
Operating cash flow per share | 108.29 | 104.1 | 102.49 | 110.83 | 115.03 | |
Free cash flow per share | 108.29 | 104.1 | 102.49 | 110.83 | 115.03 | |
Cash per share | 176.63 | 676.01 | 347.97 | 345.1 | 316.84 | |
Book value per share | 2.26K | 2.14K | 2.14K | 2.16K | 2.15K | |
Tangible book value per share | 2.24K | 2.44K | 2.45K | 2.52K | 2.51K | |
Share holders equity per share | 2.26K | 2.14K | 2.14K | 2.16K | 2.15K | |
Interest debt per share | 2.18K | 2.54K | 2.47K | 2.45K | 2.6K | |
Market cap | 88.89B | 92.22B | 90.69B | 94.9B | 93.12B | |
Enterprise value | 267.01B | 256.68B | 277.22B | 280.52B | 294.01B | |
P/E ratio | -18.35 | -2.21 | -44.63 | 9.42 | -53.15 | |
Price to sales ratio | 0.91 | 0.91 | 0.93 | 0.93 | 0.86 | |
POCF ratio | 9.22 | 9.98 | 10.05 | 9.72 | 9.19 | |
PFCF ratio | 9.22 | 9.98 | 10.05 | 9.72 | 9.19 | |
P/B Ratio | 0.44 | 0.49 | 0.48 | 0.5 | 0.49 | |
PTB ratio | 0.44 | 0.49 | 0.48 | 0.5 | 0.49 | |
EV to sales | 2.74 | 2.54 | 2.86 | 2.74 | 2.72 | |
Enterprise value over EBITDA | 513.47 | -923.32 | -1.22K | 166.09 | 171.84 | |
EV to operating cash flow | 27.71 | 27.78 | 30.71 | 28.74 | 29.01 | |
EV to free cash flow | 27.71 | 27.78 | 30.71 | 28.74 | 29.01 | |
Earnings yield | -0.01 | -0.11 | -0.01 | 0.03 | 0 | |
Free cash flow yield | 0.11 | 0.1 | 0.1 | 0.1 | 0.11 | |
Debt to equity | 0.96 | 1.19 | 1.15 | 1.13 | 1.21 | |
Debt to assets | 0.37 | 0.38 | 0.38 | 0.37 | 0.39 | |
Net debt to EBITDA | 342.53 | -591.59 | -821.72 | 109.9 | 117.41 | |
Current ratio | 1.59 | 1.48 | 1.4 | 1.47 | 1.47 | |
Interest coverage | 4.98 | 1.52 | -0.28 | 7.32 | 7.45 | |
Income quality | -7.96 | -0.89 | -17.77 | 3.88 | -23.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.02 | 0 | 0 | 0 | |
Research and developement to revenue | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 832.6 | 2.37K | 527.21 | 1.18K | 489.94 | |
ROIC | 0.01 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | -0.02 | 0 | 0 | 0 | |
Graham Net | -2.15K | -2.03K | -2.06K | -2.25K | -2.38K | |
Working capital | 89.45B | 96.63B | 78.22B | 86.05B | 84.05B | |
Tangible asset value | 199.45B | 216.79B | 215.61B | 217.29B | 216.37B | |
Net current asset value | -84.62B | -68.35B | -77.75B | -87.7B | -99.18B | |
Invested capital | 0.96 | 1.19 | 1.15 | 1.13 | 1.21 | |
Average receivables | 83.37B | 83.91B | 94.17B | 91.57B | 84.05B | |
Average payables | 50.79B | 51.18B | 49.76B | 47.54B | 48.65B | |
Average inventory | 117.48B | 121.19B | 123.53B | 126.35B | 126.28B | |
Days sales outstanding | 72.82 | 79.01 | 92.27 | 73.54 | 70.45 | |
Days payables outstanding | 56.81 | 59.03 | 53.18 | 55.35 | 51.2 | |
Days of inventory on hand | 139.89 | 134.67 | 144.43 | 144.08 | 132.54 | |
Receivables turnover | 1.24 | 1.14 | 0.98 | 1.22 | 1.28 | |
Payables turnover | 1.58 | 1.52 | 1.69 | 1.63 | 1.76 | |
Inventory turnover | 0.64 | 0.67 | 0.62 | 0.62 | 0.68 | |
ROE | -0.01 | -0.05 | 0 | 0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
3101.T Frequently Asked Questions
What is Toyobo Co., Ltd. stock symbol ?
Toyobo Co., Ltd. is a JP stock and trading under the symbol 3101.T
What is Toyobo Co., Ltd. stock quote today ?
Toyobo Co., Ltd. stock price is $1093 today.
Is Toyobo Co., Ltd. stock public?
Yes, Toyobo Co., Ltd. is a publicly traded company.